Home > Insider Trading > Filing (0001415889-18-000763)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
816284	Celgene Corp	CELG	Pharmaceutical Preparations (2834)	222711928

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1538897	J Mark Alles	86 Morris Avenue Summit NJ 07901	Ceo, Chairman Of Board	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-09	1,208	$82.60	187,316	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2018-05-08	59,234	$0.00	59,234	$83.13
Common Stock	Restricted Stock Unit	Acquisiton	2018-05-08	30,079	$0.00	30,079	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
59,234		2028-05-08	No	4	A	Direct
30,079			No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,056	Indirect	401(k) Plan

Footnotes

Option is immediately exercisable and will vest in four equal installments, commencing on May 8, 2019.
The option was issued pursuant to the Company's 2017 Stock Incentive Plan.
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The restricted stock units will fully vest on May 8, 2021. Vested shares will be delivered to the reporting person promptly after the vesting date.
The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan.